Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital ...

Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.

Research Alliance III follows a few months after Cormorant Asset Management priced a $150 million IPO for its own blank-check ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin ...

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from ...

Market News UpdatesNews Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness, recovery, longevity, weight management, and ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. The ...

Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and ...

The nonprofit is aiming to inspire a new moonshot effort that helps the U.S. maintain its position as a drug innovation ...

Biotechnology company GNQ Insilico is relocating its North American headquarters and lab to Greenville. The company uses artificial intelligence to develop drugs for diseases like cancer and metabolic ...